EP Patent

EP3240579A2 — Lipid-encapsulated gas microsphere compositions and related methods

Assigned to Lantheus Medical Imaging Inc · Expires 2017-11-08 · 9y expired

What this patent protects

The invention provides, inter alia, improved lipid formulations used to generate lipid-encapsulated gas microspheres, and methods of their use.

USPTO Abstract

The invention provides, inter alia, improved lipid formulations used to generate lipid-encapsulated gas microspheres, and methods of their use.

Drugs covered by this patent

perflutren (PERFLUTREN)

Patent Metadata

Patent number: EP3240579A2
Jurisdiction: EP
Classification: —
Expires: 2017-11-08
Drug substance claim: No
Drug product claim: No
Assignee: Lantheus Medical Imaging Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.